Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) was the recipient of a significant decrease in short interest during the month of August. As of August 31st, there was short interest totalling 14,992,761 shares, a decrease of 14.4% from the August 15th total of 17,507,915 shares. Based on an average daily trading volume, of 3,589,063 shares, the days-to-cover ratio is presently 4.2 days. Currently, 23.7% of the shares of the stock are sold short.
Several brokerages have weighed in on SBRA. Zacks Investment Research cut shares of Sabra Healthcare REIT from a “buy” rating to a “hold” rating in a research note on Friday. Jefferies Group LLC raised shares of Sabra Healthcare REIT from a “hold” rating to a “buy” rating and set a $25.00 price objective on the stock in a research note on Tuesday, August 15th. BidaskClub lowered shares of Sabra Healthcare REIT from a “sell” rating to a “strong sell” rating in a research report on Wednesday, August 16th. Stifel Nicolaus reiterated a “hold” rating and set a $26.00 target price on shares of Sabra Healthcare REIT in a research report on Friday, July 28th. Finally, ValuEngine lowered shares of Sabra Healthcare REIT from a “buy” rating to a “hold” rating in a research report on Friday, September 1st. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and three have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $25.00.
Sabra Healthcare REIT (NASDAQ SBRA) opened at 22.18 on Friday. Sabra Healthcare REIT has a one year low of $19.30 and a one year high of $29.10.
Several institutional investors have recently made changes to their positions in the stock. Phocas Financial Corp. grew its holdings in shares of Sabra Healthcare REIT by 4.7% during the 2nd quarter. Phocas Financial Corp. now owns 212,756 shares of the real estate investment trust’s stock valued at $5,127,000 after purchasing an additional 9,470 shares during the last quarter. Cetera Investment Advisers bought a new stake in Sabra Healthcare REIT during the 2nd quarter worth approximately $505,000. Wasatch Advisors Inc. grew its holdings in Sabra Healthcare REIT by 14.5% during the 2nd quarter. Wasatch Advisors Inc. now owns 570,029 shares of the real estate investment trust’s stock worth $13,738,000 after acquiring an additional 72,125 shares during the last quarter. Koch Industries Inc. bought a new stake in Sabra Healthcare REIT during the 2nd quarter worth approximately $739,000. Finally, Piedmont Investment Advisors LLC bought a new stake in Sabra Healthcare REIT during the 2nd quarter worth approximately $340,000. 99.26% of the stock is currently owned by institutional investors.
TRADEMARK VIOLATION WARNING: This piece of content was reported by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this piece of content on another publication, it was stolen and republished in violation of U.S. and international trademark and copyright laws. The correct version of this piece of content can be viewed at https://stocknewstimes.com/2017/09/22/sabra-healthcare-reit-inc-sbra-short-interest-down-14-4-in-august.html.
Sabra Healthcare REIT Company Profile
Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.
Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with MarketBeat.com's FREE daily email newsletter.